Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/07/2010US7790202 functions as a sunscreen, an anti-perspirant, an insect/pest repellant and/or an antiseptic; zinc oxide powder, peppermint powder, basil powder, rosemary powder, eucalyptus powder, copper mica powder, and silica powder spheres
09/07/2010US7790200 Formulation and process for drug loaded cores
09/07/2010US7790199 Such as capsules/beads of cyclobenzaprine hydrochloride; drug delivery system is designed for once-daily oral administration to maintain an adequate plasma concentration time profile, thereby providing relief of muscle spasms
09/07/2010US7790198 Preparation and administration form comprising an acid-labile active compound
09/07/2010US7790197 Wet granulated particle form; compression; milling; benign prostate hyperplasia ; anticholesterol agents; antilipemic agents; Alzheimer's disease
09/07/2010US7790194 Combining acrylamide and methylene bis-acrylamide, adding radical initiatiator and washing with pyrogen-free water or saline solution; for lip augmentation/reconstruction
09/07/2010US7790193 Inhibiting proliferation with a matrix of alginate polymers and Strontium coated onto a medical, implantable device: a stent, a cardiac pacemaker, a catheter, a implantable prosthetic, a surgical screw, a surgical wire, a tissue bulking implant
09/07/2010US7790190 Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid
09/07/2010US7790189 Triple helical oligonucleotide comprising polysaccharide carrier and unmethylated CpG motif for use as DNA vaccine in treatment of infection and metabolic disorders
09/07/2010US7790182 Protein vaccines against poxviruses
09/07/2010US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790150 acetal resin or ketone polymer conjugate; drug covalently attached to polymer via succinamide linkages; the succinamidoester is oriented such that an ester is formed at the carrier side while the carboxyl forms amide bond with an amine-containing drug; glycine link; drug delivery; camptothecin CPT, Taxol
09/07/2010US7790145 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent
09/07/2010US7790142 Using a radiolabeled fatty acid analog such as endo-[18F] fluoro- or [123I]iodo-3,4-cyclopropylheptadecanoic acid localized in tissue of interest, imaging, determining blood flow rate
09/07/2010US7790102 Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
09/07/2010US7789841 Method and apparatus for connective tissue treatment
09/07/2010US7789610 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/07/2010CA2608864C Recombinant mva virus, and the use thereof
09/07/2010CA2596274C Recombinant mva virus, and the use thereof
09/07/2010CA2582452C Pegylated liposomal doxorubicin in combination with ecteinascidin 743
09/07/2010CA2562801C Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia
09/07/2010CA2539729C Isoquinolinone potassium channel inhibitors
09/07/2010CA2521081C Pyrimidin-4-one derivatives and their use as p38 kinase modulators
09/07/2010CA2512193C 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
09/07/2010CA2509218C 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as edg receptor agonists
09/07/2010CA2496721C New process for synthesizing derivatives of 1,3-dihydro-2h-3-benzazepin-2-one and its application to the synthesis of ivabradine and its pharmaceutically acceptable acid addition salts
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2492081C Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/07/2010CA2490326C Photodynamic therapy for vascular diseases
09/07/2010CA2485349C A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor
09/07/2010CA2474448C Inactivation of west nile virus and malaria using photosensitizers
09/07/2010CA2457401C Transdermal therapeutic system containing fentanyl or related substances
09/07/2010CA2457245C Transdermal therapeutic system (tts) containing the active substance fentanyl
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/07/2010CA2438854C Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method
09/07/2010CA2414774C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
09/07/2010CA2375810C Beta2-adrenoceptor agonists
09/07/2010CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/07/2010CA2368676C Sphingomyelin containing preparation
09/07/2010CA2351273C Solution of n-[o-(p-pivaloyloxybenzenesulfonylamino) benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
09/07/2010CA2338172C Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
09/07/2010CA2334615C Production process for polymeric micelle charged therein with drug and polymeric micelle composition
09/07/2010CA2282066C Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria
09/07/2010CA2179935C Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
09/05/2010CA2679784A1 Diagnostic, prognostic and treatment methods
09/05/2010CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation
09/02/2010WO2010099546A1 Method of reducing brain cell damage or death
09/02/2010WO2010099542A2 Formulations of atp and analogas of atp
09/02/2010WO2010099526A1 Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activity
09/02/2010WO2010099522A1 Enhanced migraine treatments based on ghrelin mimetics
09/02/2010WO2010099508A1 Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
09/02/2010WO2010099503A1 Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
09/02/2010WO2010099502A1 Compositions, synthesis, and methods of utilizing arylpiperazine derivatives
09/02/2010WO2010099458A1 Combination of a nucleoside polymerase inhibitor with a macrocyclic protease inhibitor and use thereof in the treatment of hepatitis c, liver fibrosis and impaired liver function
09/02/2010WO2010099445A2 Non-covalent inhibition of the 26s proteasome and uses thereof
09/02/2010WO2010099388A1 Combinational use of a pde3 inhibitor and other agents
09/02/2010WO2010099379A1 Jak kinase modulating quinazoline derivatives and methods of use thereof
09/02/2010WO2010099368A1 Ocular implants comprising kinase inhibitors
09/02/2010WO2010099341A1 Compositions and methods for inhibiting expression of mig-12 gene
09/02/2010WO2010099323A1 Crystalization of pharmaceutical compounds
09/02/2010WO2010099255A1 Composition and drug delivery of bisphosphonates
09/02/2010WO2010099217A1 Modulation of neurogenesis using d-cycloserine combinations
09/02/2010WO2010099212A1 Otic compositions useful for the treatment of infections of the internal and external ear in mammals
09/02/2010WO2010099169A2 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1
09/02/2010WO2010099166A1 Thienopyridine derivatives for the treatment and prevention of dengue virus infections
09/02/2010WO2010099159A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
09/02/2010WO2010099150A1 Pharmaceutical tablet and process
09/02/2010WO2010099139A2 Combination anti-cancer therapy
09/02/2010WO2010099098A1 Stereoselective hydrogenation of a ketone
09/02/2010WO2010099064A1 Iminosugars and methods of treating arenaviral infections
09/02/2010WO2010099062A1 Oral care compositions for treating xerostomia
09/02/2010WO2010099039A1 Indole derivatives as crth2 receptor antagonists
09/02/2010WO2010098994A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
09/02/2010WO2010098906A1 Liquid statin formulations
09/02/2010WO2010098888A1 Uses of chemicals to modulate gsk-3 signaling for treatment of bipolar disorder and other brain disorders
09/02/2010WO2010098886A1 Polyamine inhibitors for the treatment and prevention of parkinson's disease
09/02/2010WO2010098866A1 Cyclopentathiophene/cyclohexathiophene dna methyltransferase inhibitors
09/02/2010WO2010098843A2 Peptoid oligomers, pharmaceutical compositions and methods of using the same
09/02/2010WO2010098839A1 Pde 1 inhibitors for ophthalmic disorders
09/02/2010WO2010098822A1 Prebiotic formulations and methods of use
09/02/2010WO2010098625A2 Pharmaceutical preparation
09/02/2010WO2010098600A2 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/02/2010WO2010098495A1 Imidazolylpyrazine derivatives
09/02/2010WO2010098490A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
09/02/2010WO2010098488A1 Aryl imidazole compounds and their use as beta amyloid production inhibitors
09/02/2010WO2010098487A1 Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors
09/02/2010WO2010098484A1 Process for producing carotenoid
09/02/2010WO2010098482A1 Stable capsule preparation and method for producing same
09/02/2010WO2010098475A1 Agent for prevention and treatment of eating disorders
09/02/2010WO2010098442A1 Carbon monoxide removal agent
09/02/2010WO2010098433A1 Coenzyme q10-containing composition for oral ingestion
09/02/2010WO2010098428A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst
09/02/2010WO2010098396A1 Process for producing phenyl-substituted heterocyclic derivative
09/02/2010WO2010098367A1 Pyrimidopyrimidoindazole derivative
09/02/2010WO2010098365A1 Nucleoside-type antibiotic
09/02/2010WO2010098344A1 Tricyclic pyrazolopyrimidine derivative
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
1 ... 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 ... 7860